Furthermore, the costs associated with cancer treatment and ACT in the first year showed an increasing trend (Supplementary Figs. 2 and 3 ).
← all excerpts
Cost-effectiveness analysis of gene-expression-based prognostic tests for patients with early-stage breast cancer in South Korea.
1
—
—